raloxifene hydrochloride has been researched along with norfloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Gao, Y; Wu, J; Zhou, J | 1 |
| Chandal, N; Mahey, N; Nandanwar, H; Tambat, R; Thakur, KG; Verma, DK | 1 |
1 review(s) available for raloxifene hydrochloride and norfloxacin
| Article | Year |
|---|---|
Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
Topics: Antineoplastic Agents; Drug Discovery; Drug Repositioning; Humans; Norfloxacin; Pyridoxal; Raloxifene Hydrochloride; Small Molecule Libraries; Sulfonamides; Sulindac | 2016 |
1 other study(ies) available for raloxifene hydrochloride and norfloxacin
| Article | Year |
|---|---|
Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carrier Proteins; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Norfloxacin; Pyrvinium Compounds; Raloxifene Hydrochloride; Staphylococcal Infections; Staphylococcus aureus | 2021 |